Microbiological data for patients with febrile neutropenia

被引:42
作者
Kanamaru, A [1 ]
Tatsumi, Y [1 ]
机构
[1] Kinki Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Osaka 5898511, Japan
关键词
D O I
10.1086/383042
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pattern of bacterial infections and antimicrobial susceptibility has changed significantly during the past 20 - 30 years. The causative organisms for bacteremia or fungemia identified at Kinki University Hospital in 1985 - 1996 were compared with the isolates identified during 1997 - 2002. The prevalence of gram-negative organisms decreased, whereas the prevalence of gram-positive organisms increased. Staphylococcal species predominated in the second period, accounting for 22% of isolates, and methicillin-resistant Staphylococcus aureus (MRSA) increased from 5% to 14% of isolates. Pseudomonas aeruginosa ranked second, although the prevalence decreased in the second period compared with the first. Candida species were also relatively frequent (11%). Enterococcal species had an 8% prevalence. A comparison of all culture isolates showed that gram-negative isolates still predominated among the general patient population, whereas almost equal prevalence was observed in patients with hematological diseases. MRSA was the organism most frequently isolated in the general patient population, followed by P. aeruginosa. Among staphylococcal species, MRSA accounted for as much as 90% of isolates.
引用
收藏
页码:S7 / S10
页数:4
相关论文
共 13 条
[1]   PIPERACILLIN-TAZOBACTAM PLUS AMIKACIN VERSUS CEFTAZIDIME PLUS AMIKACIN AS EMPIRIC THERAPY FOR FEVER IN GRANULOCYTOPENIC PATIENTS WITH CANCER [J].
COMETTA, A ;
ZINNER, S ;
DEBOCK, R ;
CALANDRA, T ;
GAYA, H ;
KLASTERSKY, J ;
LANGENAEKEN, J ;
PAESMANS, M ;
VISCOLI, C ;
GLAUSER, MP ;
GIBSON, B ;
SANZ, M ;
HANN, IM ;
FOLLATH, F ;
FATIO, R ;
FERSTER, A ;
VANHOOF, A ;
VANLANDUYT, H ;
ARENDT, V ;
HEMMER, R ;
PEETERMANS, M ;
PADMOS, A ;
SEITANIDES, B ;
HATZIYANNI, M ;
LOPEZ, A ;
PORCELLINI, A ;
GREK, V ;
CABALLERO, D ;
TOGNI, P ;
GALLAGHER, JG ;
GARAVENTA, A ;
MASSIMO, L ;
SUGAR, A ;
LEGRAND, JC ;
OPPENHEIM, B ;
PETRIKKOS, G ;
BEYTOUT, J ;
NIKOSKELAINEN, J ;
SHAPIRO, M ;
ESTAVOYER, JM ;
KERN, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) :445-452
[2]   Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer [J].
Cometta, AF ;
Calandra, T ;
Gaya, H ;
Zinner, SH ;
deBock, R ;
DelFavero, A ;
Bucaneve, G ;
Crokaert, F ;
Kern, WV ;
Klastersky, J ;
Langenaeken, J ;
Micozzi, A ;
Padmos, A ;
Paesmans, M ;
Viscoli, C ;
Glauser, MP ;
Martino, P ;
Caballero, D ;
Engelhard, D ;
Shapiro, M ;
Castagnola, E ;
Massimo, L ;
Giacchino, R ;
Sanz, M ;
Gigium, M ;
Carotenuto, M ;
Lopez, A ;
Andrien, JM ;
Paulus, R ;
Martino, B ;
Nobile, F ;
Togni, P ;
Ferster, A ;
Cudillo, L ;
Legrand, JC ;
Dinota, A ;
Cajozzo, A ;
Quintini, G ;
MartinezDalmau, A ;
Nosari, A ;
Bucaneve, GP ;
Cometta, A ;
Galazzo, M ;
Giddey, M ;
Bille, J ;
Blaser, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1108-1115
[3]   Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis [J].
Cruciani, M ;
Rampazzo, R ;
Malena, M ;
Lazzarini, L ;
Todeschini, G ;
Messori, A ;
Concia, E .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :795-805
[4]   Antimicrobial activity of gatifloxacin compared to seven other compounds tested against gram-positive organisms isolated at 10 cancer-treatment centers [J].
Diekema, DJ ;
Jones, RN ;
Rolston, KVI .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (01) :37-43
[5]   SEPTICEMIA AND SHOCK SYNDROME DUE TO VIRIDANS STREPTOCOCCI - A CASE-CONTROL STUDY OF PREDISPOSING FACTORS [J].
ELTING, LS ;
BODEY, GP ;
KEEFE, BH .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (06) :1201-1207
[6]   Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis [J].
Engels, EA ;
Lau, J ;
Barza, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1179-1187
[7]   Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution [J].
GonzalezBarca, E ;
FernandezSevilla, A ;
Carratala, J ;
Granena, A ;
Gudiol, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (04) :291-296
[8]   Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia [J].
Jones, RN .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :495-502
[9]   DETECTION OF BACTERIA IN PHAGOCYTE-SMEARS FROM SEPTICEMIA-SUSPECTED BLOOD BY IN-SITU HYBRIDIZATION USING BIOTINYLATED PROBES [J].
MATSUHISA, A ;
SAITO, Y ;
SAKAMOTO, Y ;
KESHI, H ;
UEYAMA, H ;
AIKAWA, Y ;
KISHI, Y ;
OHNO, T .
MICROBIOLOGY AND IMMUNOLOGY, 1994, 38 (07) :511-517
[10]   VIRIDANS STREPTOCOCCAL BACTEREMIA IN PATIENTS WITH NEUTROPENIA [J].
RICHARD, P ;
DELVALLE, GA ;
MOREAU, P ;
MILPIED, N ;
FELICE, MP ;
DAESCHLER, T ;
HAROUSSEAU, JL ;
RICHET, H .
LANCET, 1995, 345 (8965) :1607-1609